Commentary on “Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.” A Canadian perspective

Abstract

The criteria for mild cognitive impairment due to Alzheimer's disease (AD) and preclinical AD, while offering great hope of fostering research on primary and secondary prevention for AD, are currently unsuitable for use in general clinical practice and must be used with great caution in specialized memory clinics.